Cytomegalovirus-associated neonatal hepatitis.
Fifty-five patients with cytomegalovirus (CMV)-associated neonatal hepatitis (NH) were followed for 12 to 90 months. Six patients (10.9%) died from either a fulminant course or a chronic liver disease. Among the remaining 49 patients, whose liver function was completely recovered, there were eight with retardation of developmental or growth status, and two with hearing impairment. Overall, 20.4% of the survivors suffered from a long-term impact. The unfavorable outcome was related to several clinical and pathological parameters. These included persistence of clay-colored stool, presence of splenomegaly, ascites or anemia, high peak total and direct bilirubin, low nadir albumin levels, diffuse giant cell transformation and cirrhosis of the liver. The seropositivity of CMV infection did not significantly correlate with the outcome.
Lai
M W
MW
Department of Pediatrics, College of Medicine, National Taiwan University Hospital, Taipei, R.O.C.
Chang
M H
MH
Lee
C Y
CY
Hsu
H C
HC
Kau
C L
CL
D003586:Cytomegalovirus Infections / Q000150:complications*; D005260:Female; D006525:Hepatitis, Viral, Human / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008099:Liver / Q000473:pathology / Q000503:physiopathology; D008297:Male